MapLight Therapeutics MPLT
NASDAQ MPLT
$7.70 +0.26 (+3.49%)
As of: Nov 11, 2026 · 11:40 AM EST

MapLight Therapeutics (MPLT) Accumulated Expenses (2024 - 2026)

Updated

MapLight Therapeutics' Accumulated Expenses came in at $16.01 million for Q2 2026.

Analysis

MapLight Therapeutics (MPLT) Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2025, MapLight Therapeutics' Accumulated Expenses was $12.05 million, up 20.6% from FY2024.

  • Going back by year, Accumulated Expenses was $9.99 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 MapLight Therapeutics 338.05 Mn 33.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.01 Mn
Mar 31, 2026 10.18 Mn
Dec 31, 2025 12.05 Mn
Sep 30, 2025 14.05 Mn
Dec 31, 2024 9.99 Mn
API Access

MapLight Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=MPLT&period=max&api_key=YOUR_API_KEY